购物车
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Apoptosis
    (7)
  • Estrogen Receptor/ERR
    (5)
  • Autophagy
    (4)
  • HSP
    (4)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (14)
  • 5日内发货
    (5)
  • 20日内发货
    (4)
  • 35日内发货
    (2)
天然产物
细分筛选
搜索结果
TargetMol产品目录中 "unfolded"的结果
筛选
搜索结果
TargetMol产品目录中 "

unfolded

"的结果
  • 抑制剂&激动剂
    31
    抑制剂&激动剂
  • 化合物库
    1
    化合物库
  • 重组蛋白
    7
    重组蛋白
  • 多肽产品
    1
    多肽产品
  • 染料试剂
    3
    染料试剂
  • 天然产物
    5
    天然产物
  • Thapsigargin
    毒胡萝卜素
    TQ030267526-95-8
    Thapsigargin 属于天然产物,是一种肌/内质网 Ca2+ ATP 酶 (SERCA) 的抑制剂,也是一种内质网应激诱导剂。Thapsigargin 通过阻断细胞将钙泵入肌浆和内质网的能力来提高胞浆钙浓度。
    • ¥ 840
    现货
    规格
    数量
    TargetMol | Inhibitor Hot
    TargetMol | Citations 客户已引用
  • Guanidine hydrochloride
    盐酸胍, Guanidinium chloride, Guanidine HCl, Aminoformamidine Hydrochloride, Aminoformamidine HCl
    T041550-01-1
    Guanidine hydrochloride (Aminoformamidine Hydrochloride) 是一种强离液剂和一种蛋白质的强变性剂。
    • ¥ 99
    现货
    规格
    数量
  • (-)-Epigallocatechin
    表没食子儿茶素, l-Epigallocatechin, Epigallocatechin, EGC
    T2987970-74-1
    (-)-Epigallocatechin (Epigallocatechin) 是绿茶中含量最丰富的黄酮类天然产物,可与未折叠的天然多肽结合,阻止转化为淀粉样蛋白原纤维。
    • ¥ 310
    现货
    规格
    数量
    TargetMol | Citations 客户已引用
  • Nemorosone
    T36954351416-47-2
    Nemorosone is a polycyclic polyprenylated acylphloroglucinol (PPAP) originally isolated from C. rosea that has antiproliferative properties.1 Nemorosone inhibits growth of NB69, Kelly, SK-N-AS, and LAN-1 neuroblastoma cells (IC50s = 3.1-6.3 μM), including several drug-resistant clones, but not MRC-5 human embryonic fibroblasts (IC50 = >40 μM).2 It increases DNA fragmentation in LAN-1 cells in a dose-dependent manner, and decreases N-Myc protein levels and phosphorylation of ERK1/2 by MEK1/2. Nemorosone also inhibits growth of Capan-1, AsPC-1, and MIA-PaCa-2 pancreatic cancer cells (IC50s = 4.5-5.0 μM following a 72-hour treatment) but not human dermal and foreskin fibroblasts (IC50s = >35 μM).1 It induces apoptosis, abolishes the mitochondrial membrane potential, and increases cytosolic calcium concentration in pancreatic cancer cells in a dose-dependent manner. Nemorosone activates the caspase cascade in a dose-dependent manner and inhibits cell cycle progression, increasing the proportion of cells in the G0/G1 phase, in both neuroblastoma and pancreatic cancer cells.1,2 Nemorosone (50 mg/kg, i.p., per day) also reduces tumor growth in an MIA-PaCa-2 mouse xenograft model.3References1. Holtrup, F., Bauer, A., Fellenberg, K., et al. Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR). Br. J. Pharmacol. 162(5), 1045-1059 (2011).2. Díaz-Carballo, D., Malak, S., Bardenheuer, W., et al. Cytotoxic activity of nemorosone in neuroblastoma cells. J. Cell. Mol. Med. 12(6B), 2598-2608 (2008).3. Wold, R.J., Hilger, R.A., Hoheisel, J.D., et al. In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts. PLoS One 8(9), e74555 (2013). Nemorosone is a polycyclic polyprenylated acylphloroglucinol (PPAP) originally isolated from C. rosea that has antiproliferative properties.1 Nemorosone inhibits growth of NB69, Kelly, SK-N-AS, and LAN-1 neuroblastoma cells (IC50s = 3.1-6.3 μM), including several drug-resistant clones, but not MRC-5 human embryonic fibroblasts (IC50 = >40 μM).2 It increases DNA fragmentation in LAN-1 cells in a dose-dependent manner, and decreases N-Myc protein levels and phosphorylation of ERK1/2 by MEK1/2. Nemorosone also inhibits growth of Capan-1, AsPC-1, and MIA-PaCa-2 pancreatic cancer cells (IC50s = 4.5-5.0 μM following a 72-hour treatment) but not human dermal and foreskin fibroblasts (IC50s = >35 μM).1 It induces apoptosis, abolishes the mitochondrial membrane potential, and increases cytosolic calcium concentration in pancreatic cancer cells in a dose-dependent manner. Nemorosone activates the caspase cascade in a dose-dependent manner and inhibits cell cycle progression, increasing the proportion of cells in the G0/G1 phase, in both neuroblastoma and pancreatic cancer cells.1,2 Nemorosone (50 mg/kg, i.p., per day) also reduces tumor growth in an MIA-PaCa-2 mouse xenograft model.3 References1. Holtrup, F., Bauer, A., Fellenberg, K., et al. Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR). Br. J. Pharmacol. 162(5), 1045-1059 (2011).2. Díaz-Carballo, D., Malak, S., Bardenheuer, W., et al. Cytotoxic activity of nemorosone in neuroblastoma cells. J. Cell. Mol. Med. 12(6B), 2598-2608 (2008).3. Wold, R.J., Hilger, R.A., Hoheisel, J.D., et al. In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts. PLoS One 8(9), e74555 (2013).
    • ¥ 1080
    35日内发货
    规格
    数量
  • Mycothiazole
    TN11145114582-75-1
    Mycothiazole 是一种线粒体电子传递链 (ETC) 复合物 I 的抑制剂,在癌细胞 Huh7 (IC50为 55.8 μM)、U87 和 MCF7 中展现出细胞毒性,并在 Huh7 中诱导细胞凋亡 (apoptosis)。它通过调节未折叠蛋白反应 (UPR) 和热休克反应 (HSR) 相关的转录因子 ATFS-1 和 HSF1,延长 C. elegans 的寿命。
    • 待询
    规格
    数量